Cancer drug's use in retinal therapy has been linked with increased risks of stroke and death.
The Unintended Consequences of National Pharmacare Programs: The Experiences of Australia, New Zealand, and the UK
People on social assistance have drug coverage at very low or no cost in every province.
Provinces already employ various programs to assist vulnerable populations with medication costs.
In most countries with universal health care, patients share the cost of treatment—surgical or pharmaceutical.
Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.
National Pharmacare appears to be regarded by many as a panacea for the woes of the present hodgepodge of provincial drug plans, but some provinces seem to view it as an opportunity to alleviate the strain on their drug budgets.